Status:
WITHDRAWN
Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients
Lead Sponsor:
University of Colorado, Denver
Conditions:
Obesity
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The population continues to increase in weight. Currently there are no guidelines in the dosing of cefazolin for the obese population. Standard dosing of cefazolin 2 grams for patients \<120 kg and 3 ...
Detailed Description
The hypothesis of this study is that customary doses of antibiotics, when administered for perioperative surgical prophylaxis, are insufficient to achieve adequate antibiotic concentrations in blood a...
Eligibility Criteria
Inclusion
- BMI greater than 40
- No known history of allergy to cephalosporins
- Scheduled for elective gastric bypass or laparoscopic Roux-en-y gastric bypass procedures
- Able to read and understand English
Exclusion
- Patients \<18 years of age or \>89 Years of age
- Pregnant women, prisoners and decisionally challenged subjects will be excluded
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01886742
Start Date
September 1 2017
End Date
October 1 2018
Last Update
December 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Hospital
Aurora, Colorado, United States, 80045